Hypoxia selects Bortezomib-resistant stem cells of chronic Myeloid leukemia

PLoS ONE

Volumn 6, Issue 2, 2011, Pages

  Tanturli, Michele ^a   Giuntoli, Serena ^a   Barbetti, Valentina ^a   Rovida, Elisabetta ^a   Sbarba, Persio Dello ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN; BORTEZOMIB; CASPASE 3; ANTINEOPLASTIC AGENT; BORONIC ACID DERIVATIVE; PYRAZINE DERIVATIVE;

ADAPTATION; APOPTOSIS; ARTICLE; BLAST CELL CRISIS; BONE MARROW CELL; CANCER RESISTANCE; CANCER STEM CELL; CD34+ CELL; CELL HYPOXIA; CELL POPULATION; CELL STRAIN K 562; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; HUMAN; HUMAN CELL; LEUKEMIA STEM CELL; PROTEIN EXPRESSION; DRUG EFFECT; DRUG RESISTANCE; GENE EXPRESSION REGULATION; METABOLISM; PATHOLOGY;

ANTINEOPLASTIC AGENTS; BORONIC ACIDS; CELL HYPOXIA; DRUG RESISTANCE, NEOPLASM; FUSION PROTEINS, BCR-ABL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; K562 CELLS; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; NEOPLASTIC STEM CELLS; PYRAZINES;

EID: 79951832885     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0017008     Document Type: Article

References (13)

1. Giuntoli S, Rovida E, Barbetti V, Cipolleschi MG, Olivotto M, et al. (2006) Hypoxia suppresses BCR/Abl and selects imatinib-insensitive progenitors within clonal CML populations. Leukemia 20: 1291-1293.
2. Giuntoli S, Rovida E, Gozzini A, Barbetti V, Cipolleschi MG, et al. (2007) Severe hypoxia defines heterogeneity and selects highly immature progenitors within clonal erythroleukemia cells. Stem Cells 25: 1119-1125.
3. Giuntoli S, Tanturli M, Di Gesualdo F, Barbetti V, Rovida E, et al. (2011) Glucose availability in hypoxia regulates the selection of Chronic Myeloid Leukaemia progenitor subsets with different resistance to Imatinib-mesylate. Haematologica 96: 204-212.
4. Dello Sbarba P, Cipolleschi MG, Olivotto M, (1987) Hemopoietic progenitor cells are sensitive to the cytostatic effect of pyruvate. Exp Hematol 15: 137-142.
5. Cipolleschi MG, Dello Sbarba P, Olivotto M, (1993) The role of hypoxia in the maintenance of hematopoietic stem cells. Blood 82: 2031-2037.
6. Parmar K, Mauch P, Vergilio JA, Sackstein R, Down JD, (2007) Distribution of hematopoietic stem cells in the bone marrow according to regional hypoxia. Proc Natl Acad Sci USA 104: 5431-5436.
7. Eliasson P, Jönsson JI, (2010) The hematopoietic stem cell niche: low in oxygen but a nice place to be. J Cell Physiol 222: 17-22.
8. Heaney NB, Pellicano F, Zhang B, Crawford L, Chu S, et al. (2010) Bortezomib induces apoptosis in primitive chronic myeloid leukemia cells including LTC-IC and NOD/SCID repopulating cells. Blood 115: 2241-2250.
9. Jagani Z, Song K, Kutok JL, Dewar MR, Melet A, et al. (2009) Proteasome inhibition causes regression of leukemia and abrogates BCR-ABL-induced evasion of apoptosis in part through regulation of Forkhead tumor suppressors. Cancer Res 69: 6546-6555.
10. Albero MP, Vaquer JM, Andreu, EJ, Villanueva JJ, Franch L, et al. (2010) Bortezomib decreases Rb phosphorylation and induces caspase-dependent apoptosis in Imatinib-sensitive and-resistant Bcr-Abl1-expressing cells. Oncogene 29: 3276-3286.
11. Cipolleschi MG, Rovida E, Ivanovic Z, Praloran V, Olivotto M, et al. (2000) The expansion of murine bone marrow cells preincubated in hypoxia as an in vitro indicator of their marrow-repopulating ability. Leukemia 14: 735-739.
12. Ivanović Z, Belloc F, Faucher JL, Cipolleschi MG, Praloran V, et al. (2002) Hypoxia maintains and interleukin-3 reduces the pre-colony-forming cell potential of dividing CD34(+) murine bone marrow cells. Exp Hematol 30: 67-73.
13. Olivotto, M, Dello Sbarba P, (2008) Environmental restrictions within tumor ecosystems select for a convergent, hypoxia-resistant phenotype of cancer stem cells. Cell Cycle 7: 176-187.